Live Breaking News & Updates on Institutional trading of inovio pharmaceuticals

Stay informed with the latest breaking news from Institutional trading of inovio pharmaceuticals on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Institutional trading of inovio pharmaceuticals and stay connected to the pulse of your community

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Short Interest Up 10.8% in March

Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Free Report) was the target of a significant increase in short interest in March. As of March 15th, there was short interest totalling 2,060,000 shares, an increase of 10.8% from the February 29th total of 1,860,000 shares. Based on an average trading volume of 526,600 shares, the short-interest ratio […]

Canada , Metlife-investment-management , Inovio-pharmaceuticals , Charles-schwab-investment-management-inc , Nasdaq , Hsbc-holdings , Royal-bank , News-ratings-for-inovio-pharmaceuticals-daily , Vanguard-group-inc , Renaissance-technologies , Inovio-pharmaceuticals-inc

Inovio Pharmaceuticals (NASDAQ:INO) Cut to Sell at StockNews.com

Inovio Pharmaceuticals (NASDAQ:INO) Cut to Sell at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Inovio-pharmaceuticals-inc , Inovio-pharmaceuticals , News-ratings-for-inovio-pharmaceuticals-daily , Nasdaq , Inovio-pharmaceuticals-stock-down , Vanguard-group-inc , Millennium-management , Institutional-trading-of-inovio-pharmaceuticals , Renaissance-technologies , Capital-partners , Free-report

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded at StockNews.com

StockNews.com upgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) from a sell rating to a hold rating in a report released on Monday. Several other research analysts have also weighed in on the company. Oppenheimer upgraded Inovio Pharmaceuticals from a market perform rating to an outperform rating and set a $4.00 target price on […]

News-ratings-for-inovio-pharmaceuticals-daily , Allspring-global-investments-holdings , Green-alpha-advisors , Inovio-pharmaceuticals-inc , Inovio-pharmaceuticals , Inovio-pharmaceuticals-trading , Institutional-trading-of-inovio-pharmaceuticals , Keystone-financial-group , Free-report , Alpha-advisors , Financial-group

Inovio Pharmaceuticals (NASDAQ:INO) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a report released on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Trading Down 5.8 % INO stock opened at $0.38 on Friday. Inovio Pharmaceuticals has a one year low of $0.32 and a one […]

Blackrock-inc , Geode-capital-management , Inovio-pharmaceuticals-inc , News-ratings-for-inovio-pharmaceuticals-daily , Inovio-pharmaceuticals-company-profile , Inovio-pharmaceuticals-trading-down , Vanguard-group-inc , Renaissance-technologies , Inovio-pharmaceuticals , Institutional-trading-of-inovio-pharmaceuticals , Free-report

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Short Interest Update

Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Rating) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 42,780,000 shares, a growth of 9.0% from the May 15th total of 39,250,000 shares. Based on an average daily volume of 6,690,000 shares, the […]

Canada , Beck-bode , News-ratings-for-inovio-pharmaceuticals-daily , Capital-investment-advisors , Institutional-trading-of-inovio-pharmaceuticals , Inovio-pharmaceuticals , Brainard-capital-management , Inovio-pharmaceuticals-inc , Life-insurance-co , Nasdaq , Inovio-pharmaceuticals-price-performance

StockNews.com Upgrades Inovio Pharmaceuticals (NASDAQ:INO) to "Hold"

StockNews.com upgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Get Rating) from a sell rating to a hold rating in a research report report published on Friday morning. Separately, Royal Bank of Canada decreased their target price on Inovio Pharmaceuticals from $3.00 to $2.00 and set a sector perform rating for the company in a report […]

Canada , Metlife-investment-management , Institutional-trading-of-inovio-pharmaceuticals , Royal-bank , Inovio-pharmaceuticals , Vanguard-group-inc , Charles-schwab-investment-management-inc , Inovio-pharmaceuticals-company-profile , Hsbc-holdings , Inovio-pharmaceuticals-stock-performance , Renaissance-technologies

Inovio Pharmaceuticals (NASDAQ:INO) Rating Lowered to Underperform at Bank of America

Bank of America cut shares of Inovio Pharmaceuticals (NASDAQ:INO – Get Rating) from a neutral rating to an underperform rating in a research report sent to investors on Tuesday, Marketbeat Ratings reports. The brokerage currently has $2.00 price objective on the biopharmaceutical company’s stock. INO has been the topic of several other research reports. Royal […]

United-states , Canada , America , Davidb-weiner , Northern-trust-corp , Rafferty-asset-management , Analyst-recommendations-for-inovio-pharmaceuticals , Inovio-pharmaceuticals-inc , Institutional-trading-of-inovio-pharmaceuticals , Vanguard-group-inc , Inovio-pharmaceuticals-stock-down